Stanozolol AQ 50mg/ml – 1ml 10 apms – ZPHC

Description

Stanozolol AQ ZPHC: 50 mg/ml Injectable Solution

Stanozolol AQ 50mg/ml by ZPHC is an aqueous suspension of the anabolic steroid Stanozolol, presented in a pack of 10 ampoules each containing 1 ml. This product is formulated for athletes and bodybuilders seeking to enhance lean muscle mass, improve muscle definition, and increase strength, particularly during cutting cycles. Stanozolol is a dihydrotestosterone (DHT) derivative known for its high anabolic to androgenic ratio.

Product Features

• Manufacturer: ZPHC

• Active Ingredient: Stanozolol (micronized aqueous suspension)

• Concentration: 50 mg/ml

• Presentation: 10 ampoules × 1 ml

• Chemical Name: 17β-Hydroxy-17α-methyl-5α-androstano[3,2-c]pyrazole

• Anabolic Activity Index: 320%

• Androgenic Activity Index: 30%

• Half-Life: Approximately 9 hours

• Detection Time: Up to 2 months

Mechanism of Action
Stanozolol enhances athletic performance by binding to androgen receptors, which stimulates protein synthesis and increases nitrogen retention in muscle tissue. This process is fundamental for muscle growth and recovery. Additionally, it promotes erythropoiesis, leading to increased red blood cell production and improved oxygen delivery to muscles, which can enhance endurance. A key characteristic is its inability to aromatize into estrogen, significantly reducing the risk of estrogenic side effects such as water retention and gynecomastia.

Key Benefits for Performance Enhancement

• Lean Muscle Preservation: Aids in maintaining muscle mass during hypocaloric dieting phases.

• Enhanced Muscle Definition and Hardness: Promotes a more vascular and defined physique by reducing subcutaneous water retention.

• Increased Strength and Power: Contributes to significant gains in strength, beneficial for high-intensity training.

• Improved Endurance: Enhanced oxygen transport can support greater training volume and stamina.

• Low Estrogenic Activity: Absence of estrogen conversion reduces the risk of associated side effects, supporting a leaner appearance.

Recommended Use and Administration
Stanozolol AQ is an injectable solution intended for intramuscular administration. Due to its short half-life, frequent administration is required to maintain stable blood plasma levels. The typical dosage for performance enhancement ranges from 25 mg to 50 mg every other day. Dosage and cycle length must be tailored to the individual’s experience, goals, and response to the compound. Post-cycle therapy (PCT) is strongly recommended following the discontinuation of Stanozolol to restore natural endogenous testosterone production.

Side Effects and Precautions
The use of Stanozolol is associated with potential adverse effects. Common side effects include joint discomfort or pain, alterations in libido, and androgenic effects such as acne and increased risk of hair loss in genetically predisposed individuals. Serious health risks include hepatotoxicity (liver strain and potential damage), negative alterations to the lipid profile (increased LDL cholesterol, decreased HDL cholesterol), and cardiovascular strain. Regular health monitoring is essential. Stanozolol is contraindicated in individuals with prostate or breast cancer, severe hepatic disease, serious cardiovascular conditions, and during pregnancy or breastfeeding. Consultation with a healthcare professional is mandatory before use.

Frequently Asked Questions (FAQs)

1. What is the primary purpose of Stanozolol AQ?
   Stanozolol is primarily used to promote lean muscle mass, enhance muscle definition, and improve strength and athletic performance, often during cutting cycles.

2. What is the recommended dosage for Stanozolol AQ?
   The typical dosage is 25-50 mg every other day, but this should be determined by a healthcare professional based on individual goals and response.

3. What is the half-life of Stanozolol?
   Stanozolol has a short half-life of approximately 9 hours, requiring frequent injections to maintain stable blood levels.

4. Can Stanozolol cause estrogen-related side effects?
   No, Stanozolol does not convert to estrogen, which minimizes the risk of water retention and gynecomastia.

5. What are the common side effects of this product?
   Common side effects may include joint pain, acne, hair loss (in those predisposed), changes in libido, and increased liver enzyme levels.

6. How is Stanozolol AQ administered?
   It is administered via intramuscular injection.

7. Is post-cycle therapy (PCT) necessary after using Stanozolol?
   Yes, a well-structured post-cycle therapy protocol is essential to help restore natural testosterone production after ceasing use.

8. What is the detection time for Stanozolol?
   Stanozolol is generally detectable in the body for up to 2 months, which is a critical factor for athletes subject to doping control.

9. What are the serious health risks associated with Stanozolol?
   Serious risks include liver toxicity, negative impacts on cholesterol levels (increasing cardiovascular risk), and potential psychological effects.

10. Is it safe to combine Stanozolol with other anabolic agents?
    It is often combined with other compounds in a cycle, but this must be done with extreme caution and under professional supervision to mitigate compounded side effects and health risks.

Purchase Stanozolol AQ ZPHC to support your performance goals. Secure your supply by visiting the online store today: https://anabolicsteroidsonline.shop/

Reputable Sources

• U.S. National Library of Medicine. (n.d.). Stanozolol. MedlinePlus. Retrieved from https://medlineplus.gov/

• National Institute on Drug Abuse. (n.d.). Anabolic Steroids and Other Appearance and Performance Enhancing Drugs (APEDs). Retrieved from https://nida.nih.gov/

• World Anti-Doping Agency. (n.d.). Prohibited List. Retrieved from https://www.wada-ama.org/